Ipamorelin/CJC 1295 No DAC (5mg /5mg) – DualCore Blend

Login to view prices.

Existing research has found the following:

  • Supports Growth Hormone Release Research – Studied for its potential to stimulate natural GH secretion through synergistic GHRH and ghrelin receptor activation.

  • Explores Muscle Growth & Recovery Mechanisms – Investigated for promoting lean tissue development, endurance, and post-exertion repair.

  • Evaluates Metabolic & Fat Reduction Pathways – Examined for its effects on fat metabolism, energy utilization, and body composition in research models.

30 DAY RETURN PERIOD

100% SECURE CHECKOUT

Description

Synergistic Growth-Hormone Secretion Research

  • The combination of Ipamorelin (a selective ghrelin receptor agonist) and CJC-1295 without DAC (a growth-hormone–releasing hormone analog) has been studied in pre-clinical systems for its ability to produce synergistic stimulation of pituitary GH secretion via dual activation of GHRH and GHS-R1a pathways.

Endocrine and Metabolic Function Models

  • In animal and cell-based research, this blend has been shown to enhance GH release while maintaining physiological feedback control, making it suitable for studies of endocrine signaling, metabolic regulation, and IGF-1 pathway dynamics.

Muscle-Regeneration and Recovery Studies

  • Laboratory findings indicate that GH-axis activation from combined CJC-1295 and Ipamorelin increases myogenic signaling and protein synthesis, supporting its use in muscle-repair and recovery models.

Lipid and Metabolic-Efficiency Research

  • Experimental results show GH secretagogues may influence fat metabolism and mitochondrial activity, enabling investigations into energy balance, lipid oxidation, and metabolic rate modulation.

Tissue-Repair and Collagen-Synthesis Models

  • GH-mediated effects observed in pre-clinical studies include fibroblast activation and collagen synthesis, providing a basis for research into wound healing and extracellular matrix remodeling.

Bone-Density and Connective-Tissue Research

  • Animal data support GH-axis peptides in improving osteoblastic activity and cartilage integrity, making the combination relevant for skeletal and connective-tissue research models.

Circadian and Sleep-Related Endocrine Studies

  • GH release from CJC/Ipamorelin administration has been associated with altered sleep-phase signaling and pituitary rhythmicity, aiding investigations into circadian-endocrine coordination.

Cellular-Regeneration and Longevity Pathways

  • The dual-pathway stimulation of GH and IGF-1 has been studied for its potential influence on cellular proliferation, mitochondrial function, and stress-response adaptation in non-clinical systems.

STORAGE DETAILS: Lyophilized CJC-1295 W/O DAC & IPAMORELIN BLEND is stable at room temperature for 90 days, however it should NOT stored below freezing for any extended period of time. After reconstituting CJC-1295 W/O DAC & IPAMORELIN BLEND should be refrigerated at temperatures not to exceed 36 F.

Application: Research peptide CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH).
Appearance: Solid, white powder in 3mL glass ampule
Chemical Formula: C152H252N44O42
PubChem CID: 16129620
CAS Number: 863288-34-0
Molecular Weight: 3367.896 g/mol
Synonyms: CJC 1295 DAC, CJC-1295 with DAC
Storage: Store at ≤25°C, sealed, away from heat, light, and moisture.

Concentration: ≥98%

Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding growth-hormone enhancement, fat metabolism, or anti-aging effects in humans. End-user assumes responsibility for determining suitability for specific research protocols.

You may also like